Atlas Trials

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes

Clinical trial NCT00617565 · COMPLETED

Trial details

NCT number
NCT00617565
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Start date
2003-07-08
Primary completion
2003-11-26
Enrollment
219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.